JP2008544949A - 化膿性レンサ球菌のための免疫激性組成物および治療用組成物 - Google Patents

化膿性レンサ球菌のための免疫激性組成物および治療用組成物 Download PDF

Info

Publication number
JP2008544949A
JP2008544949A JP2007535816A JP2007535816A JP2008544949A JP 2008544949 A JP2008544949 A JP 2008544949A JP 2007535816 A JP2007535816 A JP 2007535816A JP 2007535816 A JP2007535816 A JP 2007535816A JP 2008544949 A JP2008544949 A JP 2008544949A
Authority
JP
Japan
Prior art keywords
gas
seq
protein
antigen
antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007535816A
Other languages
English (en)
Japanese (ja)
Inventor
ジュリアーノ ベンシー，
グイド グランディ，
ナタリー ノーレイズ，
マニュエル ロドリゲス ジェイ． オルテガ，
Original Assignee
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド filed Critical ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド
Publication of JP2008544949A publication Critical patent/JP2008544949A/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2007535816A 2004-10-08 2005-10-11 化膿性レンサ球菌のための免疫激性組成物および治療用組成物 Withdrawn JP2008544949A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US61685404P 2004-10-08 2004-10-08
US65273605P 2005-02-15 2005-02-15
US70112105P 2005-07-21 2005-07-21
US70520905P 2005-08-04 2005-08-04
PCT/US2005/036009 WO2006042027A2 (en) 2004-10-08 2005-10-11 Immunogenic and therapeutic compositions for streptococcus pyogenes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012071927A Division JP2012126742A (ja) 2004-10-08 2012-03-27 化膿性レンサ球菌のための免疫激性組成物および治療用組成物

Publications (1)

Publication Number Publication Date
JP2008544949A true JP2008544949A (ja) 2008-12-11

Family

ID=35720938

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007535816A Withdrawn JP2008544949A (ja) 2004-10-08 2005-10-11 化膿性レンサ球菌のための免疫激性組成物および治療用組成物
JP2012071927A Pending JP2012126742A (ja) 2004-10-08 2012-03-27 化膿性レンサ球菌のための免疫激性組成物および治療用組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012071927A Pending JP2012126742A (ja) 2004-10-08 2012-03-27 化膿性レンサ球菌のための免疫激性組成物および治療用組成物

Country Status (6)

Country Link
US (1) US7838010B2 (https=)
EP (1) EP1807446A2 (https=)
JP (2) JP2008544949A (https=)
AU (1) AU2005294275B2 (https=)
CA (1) CA2583803C (https=)
WO (1) WO2006042027A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014508783A (ja) * 2011-03-18 2014-04-10 エドゥアルド ナウウィル，アレクサンドル 免疫系を調節するための免疫原性組成物およびその使用、疾患を治療および予防する方法、細胞再生を誘発する方法、ならびに免疫応答を更新する方法

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2881568C (en) 2000-10-27 2019-09-24 Novartis Vaccines And Diagnostics, Inc. Nucleic acids and proteins from streptococcus groups a & b
AU2002216863B8 (en) * 2000-12-21 2008-03-20 Id Biomedical Corporation Streptococcus pyogenes antigens and corresponding DNA fragments
MXPA05013260A (es) * 2003-06-26 2006-03-09 Chiron Corp Composiciones inmunogenicas para chlamydia trachomatis.
ES2505695T3 (es) 2003-07-31 2014-10-10 Novartis Vaccines And Diagnostics, Inc. Composiciones inmunógenas para Streptococcus pyogenes
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
US7838010B2 (en) 2004-10-08 2010-11-23 Novartis Vaccines And Diagnostics S.R.L. Immunogenic and therapeutic compositions for Streptococcus pyogenes
EP2292644A3 (en) * 2006-07-07 2011-05-25 Intercell AG Small Streptococcus pyogenes antigens and their use
CA2668018A1 (en) * 2006-10-30 2008-09-12 Novartis Ag Immunogenic and therapeutic compositions for streptococcus pyogenes
GB0624874D0 (en) 2006-12-13 2007-01-24 Hansa Medical Ab Treatment
WO2009003291A1 (en) * 2007-07-03 2009-01-08 Mount Sinai Hospital Therapeutics and diagnostics for group a streptococci
US8071561B2 (en) 2007-08-16 2011-12-06 Chrontech Pharma Ab Immunogen platform
KR101621837B1 (ko) 2007-09-12 2016-05-17 노파르티스 아게 Ｇａｓ57 돌연변이 항원 및 ｇａｓ57 항체
GB0721757D0 (en) * 2007-11-06 2007-12-19 Novartis Ag Streptococcus pyogenes classification
EP2650014A2 (en) 2008-06-20 2013-10-16 Wyeth LLC Compositions and methods of use of ORF1358 from beta-hemolytic streptococcal strains
NZ591633A (en) * 2008-09-17 2012-10-26 Novartis Ag Combination gas vaccines and therapeutics
MX2011004755A (es) * 2008-11-05 2011-10-10 Wyeth Llc Composicion inmunogenica multicomponente para la prevencion de enfermedad estreptococica beta-hemolitica (bhs).
CN103897045A (zh) 2009-01-12 2014-07-02 诺华股份有限公司 抗革兰氏阳性细菌疫苗中的Cna_B结构域
GB0903858D0 (en) * 2009-03-05 2009-04-22 Novartis Ag Diagnosis of disease
ITMI20090946A1 (it) 2009-05-28 2010-11-29 Novartis Ag Espressione di proteine ricombinanti
GB201002362D0 (en) * 2010-02-11 2010-03-31 Isis Innovation Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds
AU2012271336B2 (en) * 2011-06-17 2017-03-02 University Of Tennessee Research Foundation Group A streptococcus multivalent vaccine
KR102730367B1 (ko) * 2014-04-15 2024-11-15 그리피스 유니버시티 그룹 a 스트렙토코쿠스 백신
BE1022553A1 (fr) * 2014-05-07 2016-05-31 Glaxosmithkline Biologicals Sa Mutants de spy0269
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
TWI598360B (zh) * 2016-12-19 2017-09-11 義守大學 Ｆｓｂｍ重組蛋白及其用途
AU2018256755A1 (en) * 2017-04-26 2019-12-05 Auckland Uniservices Limited Analytical and therapeutic methods and compositions, and uses thereof
CN108379572A (zh) * 2018-01-25 2018-08-10 暨南大学 一种化脓链球菌HtsA蛋白质疫苗以及制备方法和应用
CN110922456B (zh) * 2019-12-28 2023-02-24 重庆艾力彼生物科技有限公司 铜绿假单胞菌疫苗重组蛋白reSBP-ExoU及制备方法和应用
EP4346891A4 (en) * 2021-06-01 2025-08-13 The Regents Of Univ Of California VACCINE ANTIGEN PROTECTIVE AGAINST STREPTOCOCCOL INFECTION
GB202215414D0 (en) 2022-10-18 2022-11-30 Glaxosmithkline Biologicals Sa Vaccine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004078907A2 (en) * 2003-03-04 2004-09-16 Intercell Ag Streptococcus pyogenes antigens
WO2005032582A2 (en) * 2003-07-31 2005-04-14 Chiron Corporation Immunogenic compositions for streptococcus pyogenes

Family Cites Families (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
US4454121A (en) 1982-07-27 1984-06-12 The University Of Tennessee Research Corporation Synthetic peptides corresponding to antigenic determinants of the M protein of Streptococcus pyogenes
US5098827A (en) * 1988-02-26 1992-03-24 The University Of Florida Novel bacterial markers for pathogenic group B streptococci
US5354846A (en) * 1988-11-18 1994-10-11 Michael Kehoe Streptolysin O antigen derivatives, its production and uses
GB8827038D0 (en) 1988-11-18 1988-12-21 Kehoe M Streptolysin o antigens & uses
WO1990006951A1 (en) 1988-12-16 1990-06-28 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Pneumolysin mutants and pneumococcal vaccines made therefrom
GB2233977B (en) 1989-01-04 1993-03-31 Michael Kehoe Cytolytic streptolysin o mutants and uses
US5821088A (en) * 1990-05-11 1998-10-13 Siga Pharmaceuticals, Inc. Use of gram-positive bacteria to express recombinant proteins
US6737521B1 (en) * 1990-05-11 2004-05-18 The Rockefeller University Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
US5378620A (en) 1991-08-30 1995-01-03 Beckman Instruments, Inc. Streptolysin O derivatives
US5391712A (en) 1991-08-30 1995-02-21 Beckman Instruments, Inc. Non-hemolytic streptolysin O variants
DE4240056A1 (de) * 1992-11-28 1994-06-01 Boehringer Mannheim Gmbh Streptolysin O Peptidantigene und Verfahren zur Bestimmung von Streptolysin-Antikörper
PT613947E (pt) 1993-02-01 2004-07-30 Beckman Coulter Inc Factor mitogenico seu gene e metodo para a sua microdeteccao
WO1995000650A1 (en) * 1993-06-23 1995-01-05 Beckman Instruments, Inc. Recombinant dnase b derived from streptococcus pyogenes
US5585098A (en) * 1993-11-23 1996-12-17 Ovimmune, Inc. Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants
AU697227B2 (en) * 1994-10-07 1998-10-01 Rockefeller University, The Enzyme for cleavage of the anchor region of surface proteins from gram positive bacteria
AUPM885194A0 (en) * 1994-10-14 1994-11-10 Council Of The Queensland Institute Of Medical Research, The Synthetic peptides and vaccines comprising same
US5799981A (en) * 1995-05-12 1998-09-01 Global Healthcomm, Inc. Pharmaceutical marketing device and system
EP0743617B1 (en) * 1995-05-18 2002-03-06 Canon Kabushiki Kaisha Image processing method and apparatus thereof
US6284884B1 (en) * 1995-06-07 2001-09-04 North American Vaccine, Inc. Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
US6936259B2 (en) * 1995-06-08 2005-08-30 University Of Saskatchewan CAMP factor of Streptococcus uberis
US5819228A (en) * 1995-10-31 1998-10-06 Utilimed, Inc. Health care payment system utilizing an intensity adjustment factor applied to provider episodes of care
US6014634A (en) * 1995-12-26 2000-01-11 Supermarkets Online, Inc. System and method for providing shopping aids and incentives to customers through a computer network
US5846547A (en) * 1996-01-22 1998-12-08 Regents Of The University Of Minnesota Streptococcal C5a peptidase vaccine
US6346392B1 (en) 1996-11-27 2002-02-12 Smithkline Beecham Corporation Polynucleotides encoding a novel glutamine transport ATP-binding protein
US6272481B1 (en) * 1996-05-31 2001-08-07 Lucent Technologies Inc. Hospital-based integrated medical computer system for processing medical and patient information using specialized functional modules
IES76925B2 (en) 1996-07-03 1997-11-19 Provost Subunit Vaccine for Streptococcus Equi
EP0821070A1 (en) 1996-07-22 1998-01-28 Carelli, Claude Marcel Henri Pit-1 gene polymorphism and trait selection in animals
JP4469026B2 (ja) 1996-10-31 2010-05-26 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド Ｓｔｒｅｐｔｏｃｏｃｃｕｓ ｐｎｅｕｍｏｎｉａｅの抗原およびワクチン
JP2001510989A (ja) 1996-11-01 2001-08-07 スミスクライン・ビーチャム・コーポレイション 新規コーディング配列
US7033765B1 (en) * 1997-02-20 2006-04-25 Toronto Research Chemicals, Inc. Site-specific drug delivery
US6426074B1 (en) * 1997-03-19 2002-07-30 The Brigham And Women's Hospital Inc. Group B Streptococcus vaccine
US6256614B1 (en) * 1997-04-17 2001-07-03 Jeff H. Wecker Internet system for producing electronic reward cards
CA2289116A1 (en) * 1997-05-06 1998-11-12 Human Genome Sciences, Inc. Enterococcus faecalis polynucleotides and polypeptides
US6635623B1 (en) * 1997-06-13 2003-10-21 Baylor College Of Medicine Lipoproteins as nucleic acid vectors
ATE349527T1 (de) 1997-09-12 2007-01-15 Univ Tennessee Res Foundation Gruppe a streptokokken-impfstoff
AU9507698A (en) 1997-09-26 1999-04-23 Med Immune, Inc. (lmb) gene of (streptococcus agalactiae)
US6406883B1 (en) * 1997-09-26 2002-06-18 Luetticken Rudolf Lmb gene of Streptococcus agalactiae
US6035276A (en) * 1997-10-17 2000-03-07 Veritas Medical Services, Inc. Medical practitioner credentialing system
BR9813071A (pt) * 1997-10-17 2000-08-15 Nestle Sa Espécie de bactéria láctica
WO1999026969A1 (en) 1997-11-21 1999-06-03 University Of Otago Zoocin a immunity factor
WO1999035270A1 (en) * 1997-12-31 1999-07-15 Stressgen Biotechnologies Corporation Streptococcal heat shock proteins of the hsp60 family
US7041814B1 (en) * 1998-02-18 2006-05-09 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Enterobacter cloacae for diagnostics and therapeutics
CA2321106C (en) 1998-02-20 2013-07-23 Biochem Pharma Inc. Group b streptococcus antigens
GB9808327D0 (en) * 1998-04-20 1998-06-17 Chiron Spa Antidiotypic compounds
US6660520B2 (en) * 1998-06-05 2003-12-09 Smithkline Beecham Corporation Nrde
US7098182B2 (en) * 1998-07-27 2006-08-29 Microbial Technics Limited Nucleic acids and proteins from group B streptococcus
US6936252B2 (en) * 1998-07-27 2005-08-30 Microbial Technics Limited Streptococcus pneumoniae proteins and nucleic acid molecules
US7128918B1 (en) * 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
US6076525A (en) * 1999-01-28 2000-06-20 Hoffman; Michael D. Frame for prone surgical positioning
US7101692B2 (en) * 1999-04-15 2006-09-05 The Regents Of The University Of California Identification of sortase gene
US6833356B1 (en) * 1999-08-25 2004-12-21 Medimmune, Inc. Pneumococcal protein homologs and fragments for vaccines
CA2384713A1 (en) * 1999-09-29 2001-04-05 Human Genome Sciences, Inc. Colon and colon cancer associated polynucleotides and polypeptides
US6777547B1 (en) * 2000-01-31 2004-08-17 Andreas Podbielski Collagen-binding proteins from streptococcus pyogenes
CA2404260A1 (en) * 2000-03-21 2001-09-27 Elitra Pharmaceuticals, Inc. Identification of essential genes in prokaryotes
AUPQ801700A0 (en) * 2000-06-07 2000-06-29 Peplin Research Pty Ltd Enzyme and viral activation
JP4718099B2 (ja) * 2000-07-06 2011-07-06 アイディー バイオメディカル コーポレイション ストレプトコッカス・パイオジェンス抗原
WO2002012294A2 (en) * 2000-08-08 2002-02-14 St. Jude Children's Research Hospital Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
WO2002057315A2 (en) * 2000-10-10 2002-07-25 University Of Tennessee Research Corporation Streptococcal streptolysin s vaccines
US7160547B2 (en) * 2000-10-10 2007-01-09 University Of Tennessee Research Corporation Streptococcal streptolysin S vaccines
CA2881568C (en) * 2000-10-27 2019-09-24 Novartis Vaccines And Diagnostics, Inc. Nucleic acids and proteins from streptococcus groups a & b
GB0107658D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
US20070128229A1 (en) * 2002-04-12 2007-06-07 Wyeth Surface proteins of Streptococcus pyogenes
BR0208874A (pt) * 2001-04-13 2004-06-22 Wyeth Corp Proteìnas superficiais de streptococcus pyogenes
WO2002094851A2 (en) * 2001-05-18 2002-11-28 The Government Of The United States Of America, Asrepresented By The Secretary, Department Of Healthand Human Services, Centers For Disease Control And Prevention, Technology Transfer Office Peptide vaccines against group a streptococci
GB0118249D0 (en) * 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
US20060073530A1 (en) * 2001-08-15 2006-04-06 Olaf Schneewind Methods and compositions involving sortase B
US20040029129A1 (en) * 2001-10-25 2004-02-12 Liangsu Wang Identification of essential genes in microorganisms
GB2385274B (en) * 2002-02-13 2004-04-14 Ming-Jeng Shue Vaginal suppository delivery device
US20050181388A1 (en) * 2002-04-02 2005-08-18 Affinium Pharmaceuticals, Inc. Novel purified polypeptides from bacteria
WO2003087353A2 (en) * 2002-04-08 2003-10-23 Affinium Pharmaceuticals, Inc. Purified polypeptides involved in membrane biogenesis
GB0210128D0 (en) * 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
US20070053924A1 (en) * 2002-08-26 2007-03-08 Herve Tettelin Conserved and specific streptococcal genomes
ES2504166T3 (es) * 2002-09-13 2014-10-08 Novartis Vaccines And Diagnostics, Inc. Vacuna de estreptococo del grupo B
TW566366U (en) * 2002-09-27 2003-12-11 Wus Tech Co Ltd Labor-saving portable battery equipment for power-driven walking assisted scooter
JP5116971B2 (ja) * 2002-10-15 2013-01-09 インターセル アーゲー Ｂ群連鎖球菌の接着因子をコードする核酸、ｂ群連鎖球菌の接着因子、およびその使用
EP2289907A3 (en) * 2003-05-07 2011-08-31 Intercell AG Streptococcus agalactiae antigens I + II
AU2003904237A0 (en) * 2003-08-08 2003-08-21 Garvan Institute Of Medical Research Novel translocation assay
US8945589B2 (en) * 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
US7424370B2 (en) * 2004-02-06 2008-09-09 Council Of Scientific And Industrial Research Computational method for identifying adhesin and adhesin-like proteins of therapeutic potential
US20060041961A1 (en) * 2004-03-25 2006-02-23 Abad Mark S Genes and uses for pant improvement
WO2005108419A1 (en) 2004-05-07 2005-11-17 Lea-Ann Kirkham Mutant cholesterol-binding cytolysin proteins
JP2008508320A (ja) * 2004-07-29 2008-03-21 カイロン コーポレイション Ｓｔｒｅｐｔｏｃｏｃｃｕｓａｇａｌａｃｔｉａｅのようなグラム陽性細菌に対する免疫原性組成物
AU2005335216A1 (en) * 2004-10-05 2007-02-15 Wyeth Probe arrays for detecting multiple strains of different species
US7838010B2 (en) 2004-10-08 2010-11-23 Novartis Vaccines And Diagnostics S.R.L. Immunogenic and therapeutic compositions for Streptococcus pyogenes
JP2008525033A (ja) * 2004-12-22 2008-07-17 ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド Ｂ群連鎖球菌
EP1770171A1 (en) 2005-09-29 2007-04-04 Universität Zu Köln DNA microarray for rapid identification of Candida albicans in blood cultures.
EP2292644A3 (en) 2006-07-07 2011-05-25 Intercell AG Small Streptococcus pyogenes antigens and their use
EP2537857B1 (en) * 2007-12-21 2017-01-18 GlaxoSmithKline Biologicals SA Mutant forms of streptolysin O

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004078907A2 (en) * 2003-03-04 2004-09-16 Intercell Ag Streptococcus pyogenes antigens
WO2005032582A2 (en) * 2003-07-31 2005-04-14 Chiron Corporation Immunogenic compositions for streptococcus pyogenes

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
JPN5007017414; ＮＡＫＡＧＡＷＡ　ＩＣＨＩＲＯ: ＧＥＮＯＭＥ　ＲＥＳＥＡＲＣＨ Ｖ１３　Ｎ６Ａ, 200306, Ｐ１０４２-１０５５ *
JPN5007017415; ＳＭＯＯＴ　Ｊ　Ｃ: ＰＲＯＣＥＥＤＩＮＧＳ　ＯＦ　ＴＨＥ　ＮＡＴＩＯＮＡＬ　ＡＣＡＤＥＭＹ　ＯＦ　ＳＣＩＥＮＣＥＳ　ＯＦ　ＵＳＡ Ｖ９９　Ｎ７, 20020402, Ｐ４６６８-４６７３, ＮＡＴＩＯＮＡＬ　ＡＣＡＤＥＭＹ　ＯＦ　ＳＣＩＥＮＣＥ *
JPN5007017416; ＢＡＮＫＳ　Ｄ　Ｊ: ＪＯＵＲＮＡＬ　ＯＦ　ＩＮＦＥＣＴＩＯＵＳ　ＤＩＳＥＡＳＥＳ Ｖ１９０　Ｎ４, 20040815, Ｐ７２７-７３８ *
JPN5007017417; ＦＥＲＲＥＴＴＩ　Ｊ　Ｊ: ＰＲＯＣＥＥＤＩＮＧＳ　ＯＦ　ＴＨＥ　ＮＡＴＩＯＮＡＬ　ＡＣＡＤＥＭＹ　ＯＦ　ＳＣＩＥＮＣＥＳ　ＯＦ　ＵＳＡ Ｖ９８　Ｎ８, 20010410, Ｐ４６５８-４６６３, ＮＡＴＩＯＮＡＬ　ＡＣＡＤＥＭＹ　ＯＦ　ＳＣＩＥＮＣＥ *
JPN5007017418; ＯＬＩＶＥ　Ｃ: ＶＡＣＣＩＮＥ Ｖ２０　Ｎ２１-２２, 20020621, Ｐ２８１６-２８２５, ＢＵＴＴＥＲＷＯＲＴＨ　ＳＣＩＥＮＴＩＦＩＣ． *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014508783A (ja) * 2011-03-18 2014-04-10 エドゥアルド ナウウィル，アレクサンドル 免疫系を調節するための免疫原性組成物およびその使用、疾患を治療および予防する方法、細胞再生を誘発する方法、ならびに免疫応答を更新する方法

Also Published As

Publication number Publication date
WO2006042027A3 (en) 2006-08-24
AU2005294275B2 (en) 2012-09-13
CA2583803C (en) 2014-11-25
JP2012126742A (ja) 2012-07-05
WO2006042027A8 (en) 2006-11-02
WO2006042027A2 (en) 2006-04-20
US7838010B2 (en) 2010-11-23
US20090117113A1 (en) 2009-05-07
AU2005294275A1 (en) 2006-04-20
EP1807446A2 (en) 2007-07-18
CA2583803A1 (en) 2006-04-20

Similar Documents

Publication Publication Date Title
JP2012126742A (ja) 化膿性レンサ球菌のための免疫激性組成物および治療用組成物
JP5680536B2 (ja) 組み合わせｇａｓワクチンおよび治療法
JP5656642B2 (ja) ストレプトリシンｏの変異体形態
US8377446B2 (en) Serum resistance factors of gram positive bacteria
JP2010508276A (ja) 化膿連鎖球菌のための免疫原性組成物および治療組成物
JP2014230547A (ja) Ｇａｓ５７変異体抗原およびｇａｓ５７抗体
JP2010538634A5 (https=)
AU2013203063A1 (en) Combination gas vaccines and therapeutics

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20080918

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20080918

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110927

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20111215

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20111222

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120327

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20120327

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121107

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20130207